Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5194536
Max Phase: Preclinical
Molecular Formula: C42H60N12O13S2
Molecular Weight: 1005.15
Associated Items:
ID: ALA5194536
Max Phase: Preclinical
Molecular Formula: C42H60N12O13S2
Molecular Weight: 1005.15
Associated Items:
Canonical SMILES: C[C@@H](O)[C@@H]1NC(=O)[C@@H](NC(=O)CN)CSCC(=O)CSC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC1=O
Standard InChI: InChI=1S/C42H60N12O13S2/c1-21(55)34-39(64)50-26(8-4-12-46-42(44)45)35(60)49-27(10-11-33(58)59)36(61)51-28(14-22-16-47-25-7-3-2-6-24(22)25)40(65)54-13-5-9-31(54)38(63)52-30(41(66)67)20-69-18-23(56)17-68-19-29(37(62)53-34)48-32(57)15-43/h2-3,6-7,16,21,26-31,34,47,55H,4-5,8-15,17-20,43H2,1H3,(H,48,57)(H,49,60)(H,50,64)(H,51,61)(H,52,63)(H,53,62)(H,58,59)(H,66,67)(H4,44,45,46)/t21-,26+,27+,28+,29+,30+,31+,34+/m1/s1
Standard InChI Key: RFCZYLBFJKIQNB-HLNWOGFUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1005.15 | Molecular Weight (Monoisotopic): 1004.3844 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Gonschorek P, Zorzi A, Maric T, Le Jeune M, Schüttel M, Montagnon M, Gómez-Ojea R, Vollmar DP, Whitfield C, Reymond L, Carle V, Verma H, Schilling O, Hovnanian A, Heinis C.. (2022) Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin., 65 (14.0): [PMID:35653695] [10.1021/acs.jmedchem.2c00306] |
Source(1):